Previous 10 | Next 10 |
ANN ARBOR, Mich., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report third quarter 2023 financial results before the market opens on Tuesday, November 7, 2023. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these finan...
2023-09-25 04:27:08 ET Summary Verve Therapeutics discloses Q2 2023 results, with the VERVE-101 heart-1 trial on track to deliver initial data by 4Q23. Dr. Frederick T. Fiedorek has been appointed as the new CMO, bringing extensive experience in clinical drug development and cardi...
2023-09-22 10:24:02 ET More on Esperion Therapeutics Seeking Alpha’s Quant Rating on Esperion Therapeutics Historical earnings data for Esperion Therapeutics Financial information for Esperion Therapeutics Esperion Therapeutics: Speculative Buy, Playin...
2023-09-22 10:24:02 ET More on Esperion Therapeutics Seeking Alpha’s Quant Rating on Esperion Therapeutics Historical earnings data for Esperion Therapeutics Financial information for Esperion Therapeutics Esperion Therapeutics: Speculative Buy, Playin...
2023-09-21 08:26:09 ET Neptune Wellness Solutions ( NEPT ) +48% . Murphy Canyon Acquisition ( MURF ) +17% . TradeUP Acquisition ( UPTD ) +22% . Kezar Life Sciences ( KZR ) +10% Everest Medicines Enter into an Agreement to Develop a...
Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL WASHINGTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launchin...
2023-08-29 10:25:57 ET Are you trading penny stocks this week? Chances are that if you’re reading this article, you have some intention of finding more info on cheap stocks. Thanks to the heightened level of volatility in the stock market today, traders, in particular, have turne...
2023-08-29 08:46:13 ET Summary Esperion reported Q2 bempedoic acid revenue of $20.3M; we expect the bempedoic acid to surpass the 2023 consensus numbers. The ongoing Daiichi litigation poses a significant weight on Esperion's stock price and financials, but at this valuation, risk...
2023-08-28 15:12:12 ET If you’re looking to gain an edge in the stock market today, you’ve got to have more than a list of penny stocks to watch. You need to understand how to use the wild volatility that has been created this year to your advantage. Whether there’s...
2023-08-28 14:55:43 ET More on Esperion Esperion Therapeutics, Inc. ( ESPR ) Q2 2023 Earnings Call Transcript Esperion jumps 15% as BofA double-upgrades citing near-term upside Esperion, Currax team up to co-promote cholesterol lowering drug Nexletol Espe...
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...